Clinical trial Recruiting at 1 site Observational Ages 0 to 17

Improving care for obstructive sleep apnea in children with Down syndrome

Official title: Current Status Assessment for the Development of a Protocol to Optimize the Management of Obstructive Sleep Apnea (OSA) in Children With Down Syndrome

Run by University Hospital, Strasbourg, France · NCT07334444 · Data updated 2026-11-12

This project reviews past medical records to see how children with Down syndrome were screened and surgically treated for obstructive sleep apnea at Strasbourg University Hospital and will produce a management algorithm for use in France.

Quick facts

Study typeObservational
Ages0 Years to 17 Years
SexAll
Enrollment30 (estimated)
SponsorUniversity Hospital, Strasbourg, France
Academic / other
Locations1 site (Strasbourg)
StatusRecruiting
StartedMarch 19, 2025
Main results expectedJune 2026
Study endsJune 19, 2026
Registry record updatedJanuary 12, 2026
Trial IDNCT07334444 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Children with Down syndrome aged 0–17 who had an ENT consultation or a visit to the Sleep Center at the University Hospital of Strasbourg between January 1, 2019 and December 31, 2024 and whose records do not contain a written objection to data reuse.

Probably not a fit

Children outside the 0–17 age range, those not seen at the Strasbourg ENT/Sleep Center during the study period, or whose medical files include a written objection to data reuse will not be included and are unlikely to receive direct benefit from this record review.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is a retrospective descriptive review of ENT and sleep clinic records for children with Down syndrome seen at the University Hospital of Strasbourg between January 1, 2019 and December 31, 2024. The team will document current screening practices, diagnostic pathways, and surgical treatment patterns for obstructive sleep apnea in this population. Records with a written objection to data reuse will be excluded and no new procedures will be performed on patients. The final output will be a proposed management algorithm intended for dissemination to clinicians in France.

Why it matters

Potential benefit: If successful, this work could help standardize screening and surgical management across France, leading to earlier diagnosis and improved sleep and breathing outcomes for affected children.

How similar studies have gone: Previous observational studies have documented high OSA prevalence and benefit from tailored surgical management in children with Down syndrome, but few have produced national management algorithms, so this project builds on existing evidence while addressing a gap in standardized guidance.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Child with Down syndrome,
* Aged between 0 and 17 years,
* Having been seen for an ENT consultation at the University Hospital or the Sleep Center of the University Hospital of Strasbourg between January 1, 2019, and December 31, 2024

Exclusion Criteria:

\- Presence of a written objection in the medical file of the subject (and/or their representative) to the reuse of their data for scientific research purposes.

Where it's running

  • Service d'ORL et de Chirurgie Cervico-faciale - CHU de Strasbourg - France
    Strasbourg, France
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.